Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Phthalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 known ✓ | P03372 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.82 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.82 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.61 |
| ▸ | CA12 | O43570 | 3/20 | 0.60 |
| ▸ | CA1 | P00915 | 3/20 | 0.60 |
| ▸ | CA2 | P00918 | 3/20 | 0.60 |
| ▸ | CA4 | P22748 | 3/20 | 0.60 |
| ▸ | CA7 | P43166 | 3/20 | 0.60 |
| ▸ | CA9 | Q16790 | 3/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.59 |
| ▸ | HMGB1 | P09429 | 2/20 | 0.59 |
| ▸ | HPGD | P15428 | 2/20 | 0.59 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.59 |
| ▸ | CA6 | P23280 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.58 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.58 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phthalic Acid SCHEMBL27618507 | 1.00 | ALDH1A1 (0.82) | ALDH1A1ALOX15AKR1C3CA12CA1 | |
| Phthalic Acid SCHEMBL2561870 | 1.00 | ALDH1A1 (0.82) | ALDH1A1ALOX15AKR1C3CA12CA1 | |
| Phthalic Acid SCHEMBL30100313 | 1.00 | ALDH1A1 (0.82) | ALDH1A1ALOX15AKR1C3CA12CA1 | |
| Phthalic Acid SCHEMBL8398555 | 1.00 | ALDH1A1 (0.82) | ALDH1A1ALOX15AKR1C3CA12CA1 | |
| Phthalic Acid SCHEMBL7897915 | 1.00 | ALDH1A1 (0.82) | ALDH1A1ALOX15AKR1C3CA12CA1 | |
| Phthalic Acid SCHEMBL11323294 | 1.00 | ALDH1A1 (0.82) | ALDH1A1ALOX15AKR1C3CA12CA1 | |
| Phthalic Acid SCHEMBL29358471 | 1.00 | ALDH1A1 (0.82) | ALDH1A1ALOX15AKR1C3CA12CA1 | |
| Phthalic Acid SCHEMBL6336453 | 0.97 | ALDH1A1 (0.78) | ALDH1A1ALOX15AKR1C3CA12CA1 | |
| Phthalic Acid SCHEMBL6383293 | 0.97 | ALDH1A1 (0.78) | ALDH1A1ALOX15AKR1C3CA12CA1 | |
| Phthalic Acid SCHEMBL1896598 | 0.97 | ALDH1A1 (0.78) | ALDH1A1ALOX15AKR1C3CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 96586 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260115191-A1 | Nilotinib Compositions with Enhanced Solubility | NEOFORM BIOPHARMACEUTICAL LTD (CN) | 2026-04-30 | — | — | US | claimed |
| US-12599610-B2 | Solid dosage formulations of an orexin receptor antagonist | MERCK SHARP & DOHME LLC (US) | 2026-04-14 | — | — | US | claimed |
| US-20260096994-A1 | SOLID DISPERSIONS HAVING STABILIZED EMULSION PARTICLES | BOEHRINGER INGELHEIM INT (DE) | 2026-04-09 | — | — | US | claimed |
| US-12582629-B1 | Extended-release pharmaceutical compositions of Ralinepag | INNOVATE THERAPEUTICS LLC (US) | 2026-03-24 | — | — | US | claimed |
| US-20260069544-A1 | CENTANAFADINE MULTIPHASIC CONTROLLED-RELEASE PHARMACEUTICAL FORMULATION | INNOVATE THERAPEUTICS LLC (US) | 2026-03-12 | — | — | US | claimed |
| US-20260062394-A1 | PROCESSES FOR PREPARING OXAZOLIDINONE COMPOUNDS | MERCK SHARP & DOHME LLC (US) | 2026-03-05 | — | — | US | claimed |
| EP-4680227-A1 | FORMULATIONS OF DANICOPAN AND METHODS OF USE THEREOF | Alexion Pharmaceuticals, Inc. (US) | 2026-01-21 | — | — | EP | claimed |
| WO-2025261803-A1 | NOVEL GABA-PRODUCING LEVILACTOBACILLUS BREVIS STRAIN AND ITS USE | EVONIK OPERATIONS GMBH (DE) | 2025-12-26 | — | — | WO | claimed |
| US-12502358-B1 | Centanafadine multiphasic controlled-release pharmaceutical formulation | INNOVATE THERAPEUTICS LLC (US) | 2025-12-23 | — | — | US | claimed |
| US-20250375418-A1 | 1-(NAPHTHALEN-2-YL)-3-AZABICYCLO[3.1.0]HEXANE FOR TREATING MAJOR DEPRESSIVE DISORDER | OTSUKA PHARMA CO LTD (JP) | 2025-12-11 | — | — | US | claimed |
| US-3997346-A | Method for stabilizing the image of a thermally developable photosensitive material | FUJI PHOTO FILM CO., LTD. (JA) | 1976-12-14 | — | — | US | claimed |
| US-3981984-A | Color film coating of tablets and the like | COLORCON INCORPORATED (US) | 1976-09-21 | — | — | US | claimed |
| US-3965260-A | Anti-inflammatory dipeptide | McArthur, John N. (CA) | 1976-06-22 | — | — | US | claimed |
| US-3961041-A | PARKINSON'S DISEASE | INTERX RESEARCH CORPORATION (US) | 1976-06-01 | — | — | US | claimed |
| US-3957523-A | CELLULOSE DERIVATIVES | SHINETSU CHEMICAL COMPANY (JA) | 1976-05-18 | — | — | US | claimed |
| US-3953360-A | DISPERSION OF ACTIVATED CHARCOAL IN POLYMER MATRIX | TOYO JOZO COMPANY, LTD. (JA) | 1976-04-27 | — | — | US | claimed |
| US-3951859-A | Molecular sieving particle and preparation thereof | TOYO JOZO CO., LTD. (JA) | 1976-04-20 | — | — | US | claimed |
| US-3943063-A | Preparation of microcapsules | TOYO JOZO COMPANY, LTD. (JA) | 1976-03-09 | — | — | US | claimed |
| US-3937798-A | METHOD OF CONTROLLING HYDROGEN ION CONCENTRATION BY MICROCAPSULES | FUJI PHOTO FILM CO., LTD. (JA) | 1976-02-10 | — | — | US | claimed |
| US-3933508-A | ORGANIC SILVER SALT, SILVER HALIDE, REDUCING AGENT, BINDER | FUJI PHOTO FILM CO., LTD. (JA) | 1976-01-20 | — | — | US | claimed |